Peripheral neuropathy

What it is

Peripheral neuropathy is damage to nerves outside the brain and spinal cord, and NINDS notes that more than 100 types have been identified. These peripheral nerves carry sensation, control muscles, and regulate automatic body functions such as sweating, blood pressure, digestion, and bladder function. When they are injured or diseased, people may develop numbness, tingling, burning or stabbing pain, weakness, poor balance, or autonomic symptoms such as dizziness on standing or bowel and bladder problems.

In cancer care, peripheral neuropathy is important because it can be caused by the cancer itself, nutritional deficiencies, diabetes, infections, pressure on nerves, or as a treatment side effect, especially with some chemotherapy drugs. Symptoms often start in the toes and feet and later affect the fingers and hands in a "stocking-glove" pattern because the longest nerves are affected first.

A simple way to classify neuropathy is by the nerves involved:

Type	Main features
Sensory neuropathy	Numbness, tingling, burning pain, reduced vibration or temperature sense
Motor neuropathy	Weakness, cramps, muscle wasting, foot drop
Autonomic neuropathy	Dizziness on standing, sweating changes, constipation, urinary or sexual dysfunction
Mononeuropathy	One nerve affected, such as carpal tunnel syndrome
Polyneuropathy	Many nerves affected, usually symmetrically in feet and hands

How it works

Peripheral nerves can be damaged in different ways. The axon, which is the long part of the nerve cell that carries signals, may be injured directly. The myelin sheath, which insulates the nerve and helps signals travel quickly, may also be damaged. NINDS describes disrupted nerve signaling in three broad ways: signals that should be sent are not sent, signals are sent when they should not be, or the messages are distorted.

This explains why neuropathy can cause both loss of function and abnormal sensations at the same time. A person may have numbness because normal sensory signals are reduced, but also burning or electric-shock pain because damaged nerves fire abnormally. Motor nerve injury can reduce muscle activation and lead to weakness or falls. Autonomic nerve injury can affect blood pressure control, sweating, digestion, and bladder emptying.

In oncology, chemotherapy-induced peripheral neuropathy is a common pattern. Drugs such as platinum agents, taxanes, vinca alkaloids, bortezomib, and thalidomide-related medicines can injure peripheral nerves. The risk depends on the drug, total cumulative dose, pre-existing diabetes or neuropathy, alcohol use, kidney problems, and sometimes vitamin deficiencies. Symptoms may worsen during treatment or appear after repeated cycles.

Evidence and uses

Peripheral neuropathy is not one single disease. It is a clinical problem with many causes, so treatment depends on finding and addressing the cause where possible. Common causes include diabetes, alcohol misuse, vitamin B12 deficiency, hypothyroidism, kidney disease, autoimmune disorders, infections, inherited neuropathies, trauma, compression, and toxins. In India, diabetes is a major contributor to neuropathy burden, so clinicians often check blood sugar control along with nutritional and medication history.

For people with cancer, the main practical uses of the diagnosis are to identify reversible causes, prevent worsening, and manage symptoms. If neuropathy is linked to a cancer drug, the oncology team may adjust the dose, delay treatment, switch drugs, or monitor more closely. This decision depends on the severity of symptoms and the goals of cancer treatment.

Symptom control usually combines several approaches:

1. Treat the cause when possible: improve diabetes control, correct vitamin deficiency, relieve nerve compression, or review neurotoxic medicines.
2. Reduce pain: medicines used for neuropathic pain may help some patients, though response varies.
3. Improve function and safety: physiotherapy, balance training, footwear advice, and fall prevention can be important.
4. Protect numb areas: daily foot checks, burn prevention, and skin care matter when sensation is reduced.

Evidence for many supplements marketed for neuropathy is mixed or limited. Some are studied for diabetic or chemotherapy-related neuropathy, but results are inconsistent and product quality varies. Patients should be cautious with over-the-counter combinations, especially during cancer treatment, because some may interact with medicines or add side effects. Evidence in humans is limited for many non-prescription products, and they should not replace evaluation for treatable causes.

Diagnosis / how it's measured

Diagnosis starts with the pattern of symptoms and a focused neurological examination. A clinician will ask when symptoms began, whether they started in the feet or hands, whether pain is burning or stabbing, and whether there is weakness, imbalance, constipation, urinary symptoms, or dizziness on standing. Medication history is especially important in cancer care.

The exam may assess:

• Light touch, pinprick, vibration, and temperature sensation
• Muscle strength and reflexes
• Gait and balance
• Foot skin, ulcers, deformity, or injury
• Signs of autonomic dysfunction

Tests are chosen based on the suspected cause. These may include blood glucose or HbA1c, vitamin B12, thyroid function, kidney and liver tests, and sometimes tests for infection or autoimmune disease. Nerve conduction studies and electromyography can help show whether the problem mainly affects axons or myelin and whether it is diffuse or focal. In selected cases, imaging or nerve biopsy is considered, but biopsy is not routine.

Clinicians often describe severity by how much neuropathy affects daily life. Mild neuropathy may cause tingling without functional loss. Moderate neuropathy may interfere with walking, buttoning clothes, or sleep. Severe neuropathy can cause major pain, falls, weakness, or autonomic complications.

When to see a clinician

Seek medical review promptly if you develop new numbness, tingling, burning pain, weakness, or balance problems, especially during chemotherapy. Early reporting matters because treatment changes may prevent progression.

Urgent assessment is needed if neuropathy comes with rapidly worsening weakness, trouble walking, falls, severe constipation with urinary retention, fainting, or new bowel or bladder dysfunction. These features can suggest significant motor or autonomic nerve involvement.

People with numb feet should also seek care for cuts, blisters, burns, or ulcers they may not feel properly. Loss of sensation increases the risk of unnoticed injury and infection.

Limitations and open questions

Peripheral neuropathy can be difficult to diagnose precisely because many different disorders produce similar symptoms. Even after standard testing, some people are left with an idiopathic neuropathy, meaning no clear cause is found.

Another limitation is that symptom severity does not always match test results. A person may have severe burning pain with relatively subtle nerve conduction changes, especially when small nerve fibres are involved. Standard nerve conduction studies are better for large-fibre neuropathy than small-fibre neuropathy.

In cancer care, there is still no single proven way to fully prevent chemotherapy-induced peripheral neuropathy across all drugs and patients. Research continues on risk prediction, better monitoring, and more effective treatments for numbness and pain. Evidence for many supportive therapies, including supplements and complementary approaches, remains mixed, so claims should be judged carefully.

Recovery also varies. Some neuropathies improve when the cause is corrected, while others stabilise or remain chronic. The best outcomes usually come from early recognition, treatment of reversible causes, symptom control, and practical steps to prevent falls and injuries.